MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells: potential role of ERK in VLDL-ApoB100 particle assembly.
about
Tribbles-1: a novel regulator of hepatic lipid metabolism in humansExpression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditionsModulators of hepatic lipoprotein metabolism identified in a search for small-molecule inducers of tribbles pseudokinase 1 expressionIdentification of SMEK2 as a candidate gene for regulation of responsiveness to dietary cholesterol in ratsLuminal lipid regulates CD36 levels and downstream signaling to stimulate chylomicron synthesisFunctional annotation of genomic data with metabolic inference.Identification of genes that regulate multiple cellular processes/responses in the context of lipotoxicity to hepatoma cells.A novel role for ABCA1-generated large pre-beta migrating nascent HDL in the regulation of hepatic VLDL triglyceride secretionApolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion.Involvement and mechanism of DGAT2 upregulation in the pathogenesis of alcoholic fatty liver disease.Huh-7 or HepG2 cells: which is the better model for studying human apolipoprotein-B100 assembly and secretion?From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitationsThematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis.In Vitro Analysis of the Very-Low Density Lipoprotein Export from the Trans-Golgi Network.Very-low-density lipoprotein (VLDL)-producing and hepatitis C virus-replicating HepG2 cells secrete no more lipoviroparticles than VLDL-deficient Huh7.5 cells.The many intersecting pathways underlying apolipoprotein B secretion and degradationHigh-carbohydrate diets affect the size and composition of plasma lipoproteins in hamsters (Mesocricetus auratus).The genetics of neutral lipid biosynthesis: an evolutionary perspectiveThe ever-expanding role of degradation in the regulation of apolipoprotein B metabolism.Modulation of Hepatic Protein Kinase Cβ Expression in Metabolic Adaptation to a Lithogenic DietApolipoprotein B100 biogenesis: a complex array of intracellular mechanisms regulating folding, stability, and lipoprotein assembly.JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery disease.Inhibition of the mTOR pathway: a possible protective role in coronary artery disease.Entry and release of hepatitis C virus in polarized human hepatocytes.PKCβ: Expanding role in hepatic adaptation of cholesterol homeostasis to dietary fat/cholesterol.How lipid droplets "TAG" along: Glycerolipid synthetic enzymes and lipid storage.Inhibition of MEK/ERK1/2 Signaling Affects the Fatty Acid Composition of HepG2 Human Hepatic Cell Line.Increased expression of enzymes of triglyceride synthesis is essential for the development of hepatic steatosisIncreased hepatic Fatty Acid uptake and esterification contribute to tetracycline-induced steatosis in mice.Phosphatase and tensin homolog (PTEN) regulates hepatic lipogenesis, microsomal triglyceride transfer protein, and the secretion of apolipoprotein B-containing lipoproteins.Ubiquitination regulates the assembly of VLDL in HepG2 cells and is the committing step of the apoB-100 ERAD pathway.Nobiletin attenuates VLDL overproduction, dyslipidemia, and atherosclerosis in mice with diet-induced insulin resistance.Can modulators of apolipoproteinB biogenesis serve as an alternate target for cholesterol-lowering drugs?Establishing normal metabolism and differentiation in hepatocellular carcinoma cells by culturing in adult human serum
P2860
Q26777717-B180F792-AF1C-4EB9-9075-F6E8369D555AQ28252652-949F4DC8-7512-4ED4-8520-D6C0109734A6Q28545029-3D8C718C-64C1-4BA8-882B-48DC0E678997Q28566895-D20BC8D3-C5D3-4EFD-B07C-4E721DD42028Q28578553-F5D171E2-23F7-4E93-BB69-DEC9AB4186B1Q31116096-54A8A2BD-E8ED-4029-9D3C-1C864D40FE07Q33302071-8DC919DC-93A0-429E-AD60-5A963D688481Q33741229-6057BFEB-B470-4C2D-97B7-AE98D2C0C98AQ33858526-7A254EEB-AE56-4F5D-8E8A-ABF466AF04B5Q34187979-4DA3EB47-03DE-4038-BEE2-1595E4D8CF2DQ34395165-BCB8866A-43FC-4AAE-8047-3F58DAB2E575Q34800989-1972E03D-C8D4-45A1-B703-CDC61F42B936Q34817393-CA8DF6EA-2A59-43C8-863A-D663B5215658Q36539551-6061A81E-2949-4DC5-BD98-300AC4C1B0C8Q36760026-A5784592-25A0-4793-98C8-D38CC6E309A1Q37240302-C279BE2E-00C3-4BD8-8BE8-4DD0828178A3Q37243883-004406A8-A5D9-4120-B3E3-1568438F5715Q37264190-5713D832-436F-45FD-BD16-F4968048B52DQ37339542-77B20AE8-532F-4900-9222-3C07E2F17DFBQ37635139-4D1FF257-57F3-48C6-8191-25F629BA6B2DQ37746984-F5FC820B-C11E-4EB8-ABF4-DD7D9ED71321Q37944211-9C08DCA5-43B1-45D7-A0F7-2644D2698B19Q38106486-04D40028-288E-4A4A-B890-B144504957C5Q38703848-60E60C64-DB39-4EF5-8A90-B8FB16278EFEQ39095640-A88CC7EC-C040-49EF-B428-6C9E96200499Q39392563-8764273E-15FA-4127-8847-199910A8BD65Q39420124-0B052F61-F2C9-4EFF-8895-48F6AB8053E0Q39541130-85E43453-03AE-4287-83D9-A47441A207D8Q41283943-7918908C-2D59-411E-A5F0-927EA702A55AQ41885419-18739982-B342-40F6-B9B5-806609CD66DBQ42014494-B7645B65-4C87-42B9-B521-2BEBD4F8D239Q42151368-A77D0763-BC6E-4794-85DC-2F0F32ECB748Q52600967-52FAA97C-957A-4B47-B73D-EDAA6534B326Q57112522-9C5CA4E0-4C0B-4412-9E53-E56E2C5996CC
P2860
MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells: potential role of ERK in VLDL-ApoB100 particle assembly.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
MEK-ERK inhibition corrects th ...... LDL-ApoB100 particle assembly.
@en
type
label
MEK-ERK inhibition corrects th ...... LDL-ApoB100 particle assembly.
@en
prefLabel
MEK-ERK inhibition corrects th ...... LDL-ApoB100 particle assembly.
@en
P2093
P1476
MEK-ERK inhibition corrects th ...... LDL-ApoB100 particle assembly.
@en
P2093
Julie Tsai
Khosrow Adeli
Rita Kohen-Avramoglu
P304
P356
10.1161/01.ATV.0000249861.80471.96
P407
P577
2006-10-12T00:00:00Z